Intellia Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
50%
€38.49
Target price
31.03.26
€50.00
Performance (%)
-68.33%
End price
14.12.24
€12.19
Summary
This prediction ended on 14.12.24 with a price of €12.19. Massive losses of -68.33% were the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intellia Therapeutics Inc | -4.970% | -4.970% | -15.436% | -75.117% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
According to BiotechBee what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Buy mit Kursziel 50,0